Citations

Clear

3314 citation(s) found for "Do, Alexander".

Primary Hip Arthroscopy in Patients With Acetabular Dysplasia: A Systematic Review of Published Clinical Outcomes at Minimum 5-Year Follow-up
Boos, Alexander M. , Nagelli, Christopher V. , Okoroha, Kelechi R. , Krych, Aaron J. , Krych, Aaron J , Boos, Alexander , Sierra, Rafael J. , Hevesi, Mario

Mayo Clinic

The American Journal of Sports Medicine | February 9, 2024 | Volume: 52 | Issue: 8 | Pages: 2148-2158

10.1177/03635465231197177 | PMID 38333917 Get It

Background: Hip arthroscopy in patients with borderline hip dysplasia has satisfactory outcomes at short-term follow-up; however, the data on midterm outcomes are inconsistent, and failure rates are high in some studies, limiting understanding of the role and utility of hip arthroscopy in this patient cohort. Purpose: To provide an up-to-date, evidence-based review of the clinical outcomes of primary hip arthroscopy in patients with frank or borderline hip dysplasia at ≥5-year follow-up and report the failure rate and progression to total hip arthroplasty in this cohort. Study Design: Systematic review; Level of evidence, 4. Methods: A comprehensive literature search was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Studies were included if they evaluated outcomes of primary hip arthroscopy in patients with lateral center-edge angle (LCEA) <25° at ≥5-year follow-up. Risk of bias assessment was performed using the methodological index for non-randomized studies scoring system. Level of evidence was determined using criteria from the Oxford Centre for Evidence-Based Medicine. Results: Nine studies were included in this review. Patients with LCEA <25° demonstrated satisfactory clinical outcomes, high patient satisfaction, and significant postoperative improvements in patient-reported outcomes (PROs) at follow-up ranging from a ≥5 to 10 years. Studies comparing patients with dysplasia to those without did not demonstrate significant differences in preoperative, postoperative, or delta PROs or in failure, reoperation, or revision rates. There was no overall significant correlation between outcomes and LCEA stratification. Conclusion: Hip arthroscopy in carefully selected patients with LCEA <25° can be successful at mid- to long-term follow-up and may provide clinical outcomes and failure rates comparable with patients with normal LCEA, understanding that this is a singular, 2-dimensional radiographic measure that does not differentiate instability from impingement or combinations thereof, warranting future studies delineating these differences. These findings suggest that hip dysplasia may not be an absolute contraindication for isolated hip arthroscopy and may serve as a viable intervention with consideration of staged future periacetabular osteotomy (PAO). Importantly, this review does not suggest that hip arthroscopy alters the natural history of dysplasia; therefore, patients with dysplasia should be counseled on the potential utility of PAO by appropriate hip preservation specialists.
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis
Akahoshi, Yu , Spyrou, Nikolaos , Hoepting, Matthias, Aguayo‐Hiraldo, Paibel , Ayuk, Francis , Chanswangphuwana, Chantiya , Choe, Hannah , Etra, Aaron , Grupp, Stephan A. , Schechter‐Finkelstein, Tal, Vášová, Ingrid, Wölfl, Matthias , Baez, Janna , Beheshti, Rahnuma, Eng, Gilbert, Gleich, Sigrun, Kasikis, Stelios, Katsivelos, Nikolaos , Kowalyk, Steven, Morales, George , Young, Rachel , DeFilipp, Zachariah , Ferrara, James L.M. , Nakamura, Ryotaro , Grupp, Stephan A , Hexner, Elizabeth , Hogan, William J , Merli, Pietro , Qayed, Muna , Reshef, Ran , Ullrich, Evelyn , Katsivelos, Nikolaos , DeFilipp, Zachariah , Levine, John E , Nakamura, Ryotaro , Aguayo-Hiraldo, Paibel , Akahoshi, Yu , Eder, Matthias , Hexner, Elizabeth O. , Hogan, William J. , Kitko, Carrie L. , Kraus, Sabrina , Malki, Monzr M. Al , Reshef, Ran , Zeiser, Robert , Levine, John E.

Mayo Clinic

Blood Advances | February 7, 2024 | Volume: 8 | Issue: 8 | Pages: 2047-2057

10.1182/bloodadvances.2023012091 | PMID 38324721 Get It

Abstract The absence of a standardized definition for graft-versus-host disease (GVHD) flares and data on its clinical course are significant concerns. We retrospectively evaluated 968 patients across 23 Mount Sinai Acute GVHD International Consortium (MAGIC) transplant centers who achieved complete response (CR) or very good partial response (VGPR) within 4 weeks of treatment. The cumulative incidence of flares within 6 months was 22%, and flares were associated with a higher risk of nonrelapse mortality (NRM; adjusted hazard ratio [aHR], 4.84; 95% confidence interval [CI], 3.19-7.36; P &lt; .001). Flares were more severe (grades 3/4, 41% vs 16%; P &lt; .001) and had more frequent lower gastrointestinal (LGI) involvement (55% vs 32%; P &lt; .001) than the initial GVHD. At CR/VGPR, elevated MAGIC biomarkers predicted the future occurrence of a flare, along with its severity and LGI involvement. In multivariate analyses, higher Ann Arbor (AA) biomarker scores at CR/VGPR were significant risk factors for flares (AA2 vs AA1: aHR, 1.81 [95% CI, 1.32-2.48; P = .001]; AA3 vs AA1: aHR, 3.14 [95% CI, 1.98-4.98; P &lt; .001]), as were early response to initial treatment (aHR, 1.84; 95% CI, 1.21-2.80; P = .004) and HLA-mismatched unrelated donor (aHR, 1.74; 95% CI, 1.00-3.02; P = .049). MAGIC biomarkers also stratified the risk of NRM both at CR/VGPR and at the time of flare. We conclude that GVHD flares are common and carry a significant mortality risk. The occurrence of future flares can be predicted by serum biomarkers that may serve to guide adjustment and discontinuation of immunosuppression.
Adipose Tissue Analysis Toolkit (ATAT) for automated analysis of adipocyte size and extracellular matrix in white adipose tissue
Robino, Jacob J., Plekhanov, Alexander, Jensen, Michael D. , Scherer, Philipp E. , Roberts, Charles T. , Varlamov, Oleg , Jensen, Michael , Scherer, Philipp E , Varlamov, Oleg , Zhu, Qingzhang

Mayo Clinic

Obesity | February 7, 2024 | Volume: 32 | Issue: 4 | Pages: 723-732

10.1002/oby.23992 | PMID 38321231 Get It

Abstract Objective The pathological expansion of white adipose tissue (WAT) in obesity involves adipocyte hypertrophy accompanied by expansion of the collagen‐rich pericellular extracellular matrix (ECM) and development of crown‐like structures (CLS). Traditionally, WAT morphology is assessed through immunohistochemical analysis of WAT sections. However, manual analysis of large histological sections is time‐consuming, and the available digital tools for analyzing adipocyte size and pericellular ECM are limited. To address this gap, the authors developed the Adipose Tissue Analysis Toolkit (ATAT), an ImageJ plugin facilitating analysis of adipocyte size, WAT ECM, and CLS. Methods and Results ATAT utilizes local and image‐level differentials in pixel intensity to independently threshold image background, distinguishing adipocyte‐free tissue without user input. It accurately captures adipocytes in histological sections stained with common dyes and automates the analysis of adipocyte cross‐sectional area, total‐field, and localized region‐of‐interest ECM. ATAT allows fully automated batch analysis of histological images using default or user‐defined adipocyte detection parameters. Conclusions ATAT provides several advantages over existing WAT image analysis tools, enabling high‐throughput analyses of adipocyte‐specific parameters and facilitating the assessment of ECM changes associated with WAT remodeling due to weight changes and other pathophysiological alterations that affect WAT function.
Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging
Krell‐Roesch, Janina , Syrjanen, Jeremy A. , Bezold, Jelena, Trautwein, Sandra , Barisch‐Fritz, Bettina , Boes, Klaus, Forzani, Erica , Petersen, Ronald C. , Vassilaki, Maria , Geda, Yonas E. , Geda, Yonas E , Wöll, Alexander , Kremers, Walter K. , Machulda, Mary M. , Mielke, Michelle M. , Knopman, David S.

Mayo Clinic

Advances in Alzheimer’s Disease | February 6, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/aiad230003 Get It

Background: Little is known about the association between physical activity (PA) and cognitive trajectories in older adults. Objective: To examine the association between PA and change in memory, language, attention, visuospatial skills, and global cognition, and a potential impact of sex or Apolipoprotein E (APOE) ε4 status. Methods: Longitudinal study derived from the population-based Mayo Clinic Study of Aging, including 2,060 cognitively unimpaired males and females aged ≥70 years. Engagement in midlife (ages 50–65) and late-life (last year) PA was assessed using a questionnaire. Neuropsychological testing was done every 15 months (mean follow-up 5.8 years). We ran linear mixed-effect models to examine whether mid- or late-life PA at three intensities (mild, moderate, vigorous) was associated with cognitive z-scores. Results: Light intensity midlife PA was associated with less decline in memory function compared to the no-PA reference group (time x light PA; estimate [standard error] 0.047 [0.016], p = 0.004). Vigorous late-life PA was associated with less decline in language (0.033 [0.015], p = 0.030), attention (0.032 [0.017], p = 0.050), and global cognition (0.039 [0.016], p = 0.012). Females who were physically inactive in midlife experienced more pronounced cognitive decline than females physically active in midlife and males regardless of PA (p-values for time interaction terms with midlife PA levels and sex were all p < 0.05 for global cognition). APOE ε4 carriership did not moderate the association between PA and cognition. Conclusion: Engaging in PA, particularly of vigorous intensity in late-life, was associated with less pronounced decline in global and domain-specific cognition. This association may differ by sex.
Complications of operatively treated distal radial fractures
Townsley, Sarah, Shin, Alexander Y. , Townsley, Sarah H. , Shin, Alexander Y , Pulos, Nicholas

Mayo Clinic

Journal of Hand Surgery (European Volume) | February 5, 2024 | Volume: 49 | Issue: 2 | Pages: 215-225

10.1177/17531934231192836 | PMID 38315130 Get It

Distal radial fractures represent the most common fractures of the upper extremity. Operative treatment is performed for approximately one-third of distal radial fractures in the adult population. Complications following operative treatment of distal radial fractures vary depending on the treatment modality and can be stratified into preoperative and postoperative complications. Complications can occur in the near, intermediate and long term. The most common complications seen are tendon irritation and rupture, chronic regional pain syndrome (CRPS), carpal tunnel syndrome, ulnar or radial neuropathy, compartment syndrome, malunion, inadequate fixation or loss of fixation, symptomatic hardware, post-traumatic arthritis, stiffness and infection. Careful planning, treatment and patient selection can help to mitigate these complications. Level of evidence: V
Venous and arterial thrombosis in patients with VEXAS syndrome
Kusne, Yael , Ghorbanzadeh, Atefeh , Dulau-Florea, Alina, Alcedo, Pedro E., Nghiem, Khanh, Ferrada, Marcela A. , Hines, Alexander , Quinn, Kaitlin A. , Panicker, Sumith R. , Reichard, Kaaren K. , Darden, Ivana, Goodspeed, Wendy, Durrani, Jibran , Wilson, Lorena, Olteanu, Horatiu , Lasho, Terra, Kastner, Daniel L. , Mangaonkar, Abhishek A. , Braylan, Raul C. , Beck, David B. , Patnaik, Mrinal M. , Young, Neal S. , Grayson, Peter C. , Panicker, Sumith R , Durrani, Jibran , Olteanu, Horatiu , Warrington, Kenneth J , Patnaik, Mrinal , Casanegra, Ana I , Houghton, Damon E , Groarke, Emma M , Quinn, Kaitlin A , Ferrada, Marcela A , Ghorbanzadeh, Atefeh , Shalhoub, Ruba N. , Ombrello, Amanda K. , Warrington, Kenneth J. , Go, Ronald S. , Calvo, Katherine R. , Casanegra, Ana I. , Koster, Matthew J. , Wu, Colin O. , Kanthi, Yogendra , Patel, Bhavisha A. , Houghton, Damon E.

Mayo Clinic

Blood | February 2, 2024 | Volume: 143 | Issue: 21 | Pages: 2190-2200

10.1182/blood.2023022329 | PMID 38306657 Get It

Abstract VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome, caused by somatic mutations in UBA1, is an autoinflammatory disorder with diverse systemic manifestations. Thrombosis is a prominent clinical feature of VEXAS syndrome. The risk factors and frequency of thrombosis in VEXAS syndrome are not well described, due to the disease’s recent discovery and the paucity of large databases. We evaluated 119 patients with VEXAS syndrome for venous and arterial thrombosis and correlated their presence with clinical outcomes and survival. Thrombosis occurred in 49% of patients, mostly venous thromboembolism (VTE; 41%). Almost two-thirds of VTEs were unprovoked, 41% were recurrent, and 20% occurred despite anticoagulation. The cumulative incidence of VTE was 17% at 1 year from symptom onset and 40% by 5 years. Cardiac and pulmonary inflammatory manifestations were associated with time to VTE. M41L was positively associated specifically with pulmonary embolism by univariate (odds ratio [OR]: 4.58, confidence interval [CI] 1.28-16.21, P = .02) and multivariate (OR: 16.94, CI 1.99-144.3, P = .01) logistic regression. The cumulative incidence of arterial thrombosis was 6% at 1 year and 11% at 5 years. The overall survival of the entire patient cohort at median follow-up time of 4.8 years was 88%, and there was no difference in survival between patients with or without thrombosis (P = .8). Patients with VEXAS syndrome are at high risk of VTE; thromboprophylaxis should administered be in high-risk settings unless strongly contraindicated.
Outcomes of Shoulder Instability Surgery in Competitive Wrestlers: Outcomes, Reoperations, and Return to Play at 5 Years’ Mean Follow-up
Lamba, Abhinav , Boos, Alexander M. , Wang, Allen S. , Okoroha, Kelechi R. , Krych, Aaron J. , Camp, Christopher L. , Marigi, Erick M. , Lamba, Abhinav , Boos, Alexander , Wang, Allen , Krych, Aaron J , Camp, Christopher L. , Barlow, Jonathan D.

Mayo Clinic

The American Journal of Sports Medicine | February 2, 2024 | Volume: 52 | Issue: 3 | Pages: 586-593

10.1177/03635465231218262 | PMID 38305257 Get It

Background: Wrestling is a physically demanding sport with young athletes prone to traumatic shoulder instability and a paucity of data evaluating the results of shoulder instability surgery (SIS). Purpose: To assess reoperation rates, patient-reported outcomes, and return to wrestling (RTW) after SIS in a cohort of competitive wrestlers. Study Design: Case series; Level of evidence, 3. Methods: All competitive wrestlers with a history of shoulder instability and subsequent surgery at a single institution between 1996 and 2020 were identified. All directions of shoulder instability (anterior shoulder instability [ASI], posterior shoulder instability [PSI], and traumatic multidirectional shoulder instability [TMDI]) were analyzed. Exclusions included revision SIS and <2 years of follow-up. Athletes were contacted for determination of complications, RTW, and Western Ontario Shoulder Instability Index scores. Results: Ultimately, 104 wrestlers were included with a mean age at initial instability of 16.9 years (range, 12.0-22.7 years), mean age at surgery of 18.9 years (range, 14.0-29.0 years), and a mean follow-up of 5.2 years (range, 2.0-22.0 years). A total of 58 (55.8%) wrestlers were evaluated after a single shoulder instability event, while 46 (44.2%) sustained multiple events before evaluation. ASI was the most common direction (n = 79; 76.0%), followed by PSI (n = 14; 13.5%) and TMDI (n = 11; 10.6%). Surgical treatment was most commonly an arthroscopic soft tissue stabilization (n = 88; 84.6%), with open soft tissue repair (n = 13; 12.5%) and open bony augmentation (n = 3; 2.9%) performed less frequently. RTW occurred in 57.3% of wrestlers at a mean of 9.8 months. Recurrent instability was the most common complication, occurring in 18 (17.3%) wrestlers. Revision SIS was performed in 15 (14.4%) wrestlers. Across the entire cohort, survivorship rates free from recurrent instability and revision surgery were 90.4% and 92.5% at 2 years, 71.9% and 70.7% at 5 years, and 71.9% and 66.5% at 10 years, respectively. Preoperative recurrent instability was an independent risk factor for postoperative recurrent instability (hazard ratio, 3.8; 95% CI, 1.33-11.03; P = .012). Conclusion: Competitive wrestlers with multiple dislocations before initial clinical evaluation were 3.8 times more likely to experience postoperative recurrent instability. Patients should be counseled that despite SIS, only 57.3% returned to wrestling after surgery.
Developing and describing a typology of lucid episodes among people with Alzheimer's disease and related dementias
Griffin, Joan M. , Kim, Kyungmin , Finnie, Dawn M., Gaugler, Joseph E. , Batthyány, Alexander , Bangerter, Lauren R. , Biggar, Virginia , Frangiosa, Theresa, Griffin, Joan M , Gaugler, Joseph E , Lapid, Maria I. , Kim, Kyungmin

Mayo Clinic

Alzheimer's & Dementia | February 2, 2024 | Volume: 20 | Issue: 4 | Pages: 2434-2443

10.1002/alz.13667 | PMID 38305566 Get It

AbstractINTRODUCTIONThis study examined lucid episodes among people living with late‐stage Alzheimer's disease and related dementias (PLWD) and then developed a typology of these episodes to help characterize them.METHODSFamily caregivers of PLWD provided information about witnessed episodes, including proximity to death, cognitive status, duration, communication quality, and circumstances prior to lucid episodes on up to two episodes (caregiver N = 151; episode N = 279). Latent class analysis was used to classify and characterize empirically distinct clusters of lucid episodes.RESULTSFour lucid episode types were identified. The most common type occurred during visits with family and among PLWD who lived > 6 months after the episode. The least common type coincided with family visits and occurred within 7 days of the PLWD's death.DISCUSSIONFindings suggest that multiple types of lucid episodes exist; not all signal impending death; and some, but not all, are precipitated by external stimuli.
Response to: Comment on: COG Diagnostic Imaging Committee/SPR Oncology Committee White Papers
Towbin, Alexander J. , Tang, Elizabeth , Thacker, Paul G. , McCarville, M. Beth , Thacker, Paul G , Alazraki, Adina

Mayo Clinic

Pediatric Blood & Cancer | January 31, 2024 | Volume: 71 | Issue: 4 | Pages: No page available

10.1002/pbc.30900 | PMID 38296784 Get It

Long-term results of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy (sRT) post prostatectomy.
Lukka, Himu, Pugh, Stephanie L. , Shipley, William U. , Major, Pierre , Dayes, Ian S. , Bahary, Jean-Paul , Pisansky, Thomas M. , Zeitzer, Kenneth L. , Lawton, C.A., Dess, Robert T. , Camarata, Andrew S, Balogh, Alexander G., Souhami, Luís, Seiferheld, Wendy, Feng, Felix Y. , Dess, Robert T , Dayes, Ian S , Sartor, Oliver , Efstathiou, Jason A. , Rosenthal, Seth A. , Sandler, Howard M.

Mayo Clinic

Journal of Clinical Oncology | January 29, 2024 | Volume: 42 | Issue: 4_suppl | Pages: 320-320

10.1200/jco.2024.42.4_suppl.320 Get It

320 Background: sRT is used in men with prostate cancer (PC) recurrence following radical prostatectomy (RP) signaled by a persistent or delayed elevation in PSA. It was previously reported that the use of AAT with RT improved cancer control and overall survival (OS). Long-term follow-up (FU) results are presented here. Methods: From 1998to 2003, 760 eligible post-RP patients with Stage pT3N0 or with pT2N0 and positive margins and PSA from 0.2 to 4.0 ng/mL were randomly assigned on a double-blinded, placebo-controlled trial of RT + placebo vs. RT + anti-androgen therapy (AAT) (24 months of bicalutamide, 150mg daily) during and after RT (64.8 Gy in 36 fractions prostate bed). The primary endpoint was OS estimated using Kaplan-Meier method. Time to PC death and metastatic PC (competing risk of death without an event) was estimated using cumulative incidence. The hazard ratio (HR) was obtained using Cox models (OS) and subdistribution HRs (sHRs) used the Fine-Gray model (time to PC death and metastatic PC). All tests are one-sided based on study design. Results: Median FU for surviving patients was 19 years. OS at 18 years was 53% [95% confidence interval (CI): 47-58%] for RT + AAT and 43% [95% CI: 38-48%] for RT + placebo (adjusted HR 0.82 [95% CI: 0.67-1.00], p = 0.025). The 18-year incidence of centrally reviewed PC deaths were 18% [95% CI: 14-22%] RT + AAT and 28% [95% CI: 23-32%] RT + placebo (adjusted sHR = 0.57 [95% CI: 0.42-0.78], p<0.001). The 18-year incidence of metastatic PC was 22% [95% CI: 18-26%] and 31% [95% CI: 26-35%] for AAT and placebo arms respectively with adjusted sHR = 0.59 [95% CI: 0.44-0.80, p<0.001]. Subgroup analyses is shown in the Table. Conclusions: Long term results of 24-month duration AAT during and after sRT are consistent with the primary report with significantly improved long-term OS, reduced incidence of metastatic PC and PC death for RT+AAT. Statistically significant metastatic PC was noted for Gleason score 8-10, study entry PSA>1.5 and margin positive patients and borderline significance was observed in patients with study entry PSA 0.7-1.5. Clinical trial information: NCT00002874 . [Table: see text]